The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158.
Publication
, Journal Article
Mistry, PK; Kishnani, PS; Balwani, M; Charrow, JM; Hull, J; Weinreb, NJ; Cox, TM
Published in: J Clin Med
May 4, 2023
In their paper, Hughes et al. [...].
Duke Scholars
Published In
J Clin Med
DOI
ISSN
2077-0383
Publication Date
May 4, 2023
Volume
12
Issue
9
Location
Switzerland
Related Subject Headings
- 32 Biomedical and clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Mistry, P. K., Kishnani, P. S., Balwani, M., Charrow, J. M., Hull, J., Weinreb, N. J., & Cox, T. M. (2023). The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158. J Clin Med, 12(9). https://doi.org/10.3390/jcm12093269
Mistry, Pramod K., Priya S. Kishnani, Manisha Balwani, Joel M. Charrow, Judy Hull, Neal J. Weinreb, and Timothy M. Cox. “The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158.” J Clin Med 12, no. 9 (May 4, 2023). https://doi.org/10.3390/jcm12093269.
Mistry PK, Kishnani PS, Balwani M, Charrow JM, Hull J, Weinreb NJ, et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158. J Clin Med. 2023 May 4;12(9).
Mistry, Pramod K., et al. “The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158.” J Clin Med, vol. 12, no. 9, May 2023. Pubmed, doi:10.3390/jcm12093269.
Mistry PK, Kishnani PS, Balwani M, Charrow JM, Hull J, Weinreb NJ, Cox TM. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158. J Clin Med. 2023 May 4;12(9).
Published In
J Clin Med
DOI
ISSN
2077-0383
Publication Date
May 4, 2023
Volume
12
Issue
9
Location
Switzerland
Related Subject Headings
- 32 Biomedical and clinical sciences
- 1103 Clinical Sciences